Dual action of antidepressant drugs (MAO inhibitors) on insulin release
- PMID: 1090438
- DOI: 10.1210/endo-96-3-702
Dual action of antidepressant drugs (MAO inhibitors) on insulin release
Abstract
Experiments have been carried out to investigate the role of monoamine oxidase (MAO) in the mechanism of insulin release. Isolated islets and pieces of rat pancreas were incubated in media of high glucose content in the presence of various concentrations of MAO inhibitors. At the end of the incubation, the islet MAO activity and the concentration of insulin released into the medium was measured. The results have shown that: 1. Glucose-mediated insulin release was potentiated by low concentrations of MAO inhibitors, the highest effect being observed at 10 muM. 2. Islet MAO activity was completely abolished in the presence of 10 muM of MAO inhibitors, while at lower concentrations, partial inhibition of enzyme could be achieved. A rise in the concentration of MAO inhibitors was accompanied by a decline in their potentiating effect on insulin secretion. No potentiation was observed at 1 mM concentration, and total inhibition of glucose-mediated insulin release was obtained in the presence of 5-10 mM of MA9 inhibitors. The potentiation of insulin release caused by two of the MAO inhibitors studied was abolished by addition of 1 muM epinephrine into the incubation medium. The basal rate of insulin release was insensitive to low concentrations of MAO inhibitors, but an inhibitory effect was obtained when concentrations were raised to 10 mM. In a comparative study, it was found that MAO activity was greater in liver than in islet tissue, while islets contained three times the activity of exocrine pancreas, consistent with previous findings in islet-cell tumors. The data presented here clearly show that MAO inhibitors are capable of both potentiating and inhibiting insulin release in vitro, depending on their concentrations. It is concluded that the stimulation of glucose-mediated insulin secretion may be related to the MAO inhibitory effects of the drugs, while the inhibition observed at concentrations greater than 1 times 10-3M is due to some other unidentified mechanism.
Similar articles
-
Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.Naunyn Schmiedebergs Arch Pharmacol. 1983 Nov;324(3):190-5. doi: 10.1007/BF00503893. Naunyn Schmiedebergs Arch Pharmacol. 1983. PMID: 6419132
-
Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion.Diabetologia. 1975 Dec;11(6):487-94. doi: 10.1007/BF01222097. Diabetologia. 1975. PMID: 1107123
-
Inhibition of pancreatic islet monoamine oxidase by adrenergic antagonists and ethanol.Endocr Res Commun. 1975;2(8):503-20. doi: 10.3109/07435807509050674. Endocr Res Commun. 1975. PMID: 4295
-
Characterization of pancreatic islet monoamine oxidase.Metabolism. 1975 May;24(5):581-8. doi: 10.1016/0026-0495(75)90138-9. Metabolism. 1975. PMID: 1092954
-
[ON THE MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS].Wien Klin Wochenschr. 1964 Apr 24;76:289-93. Wien Klin Wochenschr. 1964. PMID: 14223504 Review. German. No abstract available.
Cited by
-
Metabolic Effects of Oral Phenelzine Treatment on High-Sucrose-Drinking Mice.Int J Mol Sci. 2018 Sep 25;19(10):2904. doi: 10.3390/ijms19102904. Int J Mol Sci. 2018. PMID: 30257452 Free PMC article.
-
Serotonin- and Dopamine-Related Gene Expression in db/db Mice Islets and in MIN6 β-Cells Treated with Palmitate and Oleate.J Diabetes Res. 2016;2016:3793781. doi: 10.1155/2016/3793781. Epub 2016 Jun 5. J Diabetes Res. 2016. PMID: 27366756 Free PMC article.
-
Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.Naunyn Schmiedebergs Arch Pharmacol. 1983 Nov;324(3):190-5. doi: 10.1007/BF00503893. Naunyn Schmiedebergs Arch Pharmacol. 1983. PMID: 6419132
-
VMAT2 gene expression and function as it applies to imaging beta-cell mass.J Mol Med (Berl). 2008 Jan;86(1):5-16. doi: 10.1007/s00109-007-0242-x. Epub 2007 Jul 31. J Mol Med (Berl). 2008. PMID: 17665159 Review.
-
Drug interactions with oral sulphonylurea hypoglycaemic drugs.Drugs. 1977 Jan;13(1):24-34. doi: 10.2165/00003495-197713010-00003. Drugs. 1977. PMID: 401727 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources